Pharmacokinetic Assessment of Nevirapine and Metabolites in Human Immunodeficiency Virus Type 1-Infected Patients with Hepatic Fibrosis by CAMMETT, Anna Maria, MACGREGOR, Thomas R, WRUCK, Jan M, FELIZARTA, Franco, MIAILHES, Patrick, MALLOLAS, Josep, PILIERO, Peter J

Get full text

Interaction between Fosamprenavir, with and without Ritonavir, and Nevirapine in Human Immunodeficiency Virus-Infected Subjects by DEJESUS, Edwin, PILIERO, Peter J, SUMMERS, Kim, WIRE, Mary Beth, STEIN, Daniel S, MASTERMAN, Amanda, YU LOU, MIN, Sherene S, SHELTON, Mark J

Get full text

In Vitro-In Vivo Model for Evaluating the Antiviral Activity of Amprenavir in Combination with Ritonavir Administered at 600 and 100 Milligrams, Respectively, Every 12 Hours by PRESTON, Sandra L, PILIERO, Peter J, BILELLO, John A, STEIN, Daniel S, SYMONDS, William T, DRUSANO, George L

Get full text

Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients: Observational Data from the Randomized POTENT Trial by Elgadi, Mabrouk M., Piliero, Peter J.

Get full text

Guillain-Barré Syndrome Associated with Immune Reconstitution by Piliero, Peter J., Fish, Douglas G., Preston, Sandra, Cunningham, Donna, Kinchelow, Tosca, Salgo, Miklos, Qian, Jiang, Drusano, George L.

Get full text

Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical Trials by Cahn, Pedro E., Gatell, José M., Squires, Kathleen, Percival, Lisa D., Piliero, Peter J., Sanne, Ian A., Shelton, Sarah, Lazzarin, Adriano, Odeshoo, Linda, Kelleher, Thomas D., Thiry, Alexandra, Giordano, Michael D., Schnittman, Stephen M.

Request full text

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone by Bruce, R. Douglas, Altice, Frederick L, Moody, David E, Lin, Shen-Nan, Fang, Wenfang B, Sabo, John P, Wruck, Jan M, Piliero, Peter J, Conner, Carolyn, Andrews, Laurie, Friedland, Gerald H

Get full text

Early Factors in Successful Anti-HIV Treatment by Piliero, Peter J.

Request full text

Atazanavir: A Viewpoint by Peter J. Piliero by Piliero, Peter J

Get full text

Eastern Equine Encephalitis Presenting as Focal Neuroradiographic Abnormalities: Case Report and Review by Piliero, Peter J., Brody, Joshua, Zamani, Amir, Deresiewicz, Robert L.

Get full text

Pharmacokinetic interactions between buprenorphine/naloxone and by Bruce, RDouglas, Altice, Frederick L, Moody, David E, Lin, Shen-Nan, Fang, Wenfang B, Sabo, John P, Wruck, Jan M, Piliero, Peter J, Conner, Carolyn, Andrews, Laurie, Friedland, Gerald H

Get full text

Guillain-Barré Syndrome Associated with Immune Reconstitution [Abstract] by Peter J. Piliero, Douglas G. Fish, Sandra Preston, Donna Cunningham, Tosca Kinchelow, Miklos Salgo, Qian, Jiang, George L. Drusano

Get full text

Implementing a Standardized HIV Antiretroviral Order Form May Reduce Medication Errors by Faragon, John J., Fish, Douglas, Piliero, Peter J.

Get full text

Appropriate Use of Nevirapine for Long-Term Therapy [with Reply] by Leith, Jonathan, Piliero, Peter, Storfer, Stephen, Mayers, Douglas, Hinzmann, Ralf, Sanne, Ian, Rousseau, Franck, Bartlett, John A., Lederman, Michael M.

Get full text

The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy by Cooper, DA, Cordery, DV, Reiss, P, Henry, K, Nelson, M, O'Hearn, M, Reynes, J, Arastéh, K, Chung, J, Rowell, L, Guimaraes, D, Bertasso, A

Get full text